PCSS Office-Based Treatment for Opioid Use Disorders Webinar - Monday, 3/28/2022

Includes a Live Event on 03/28/2022 at 8:00 PM (EDT)

This is PART 1 of the 8-hour waiver eligibility training.
NOTE: This training has a starting time of 5:00 pm Pacific Time Zone. Please check your time zone for start time. Please download the Zoom app prior to training. https://zoom.us/ent?zcid=2582

Physicians are required to apply to the Drug Enforcement Agency for a waiver to prescribe buprenorphine, one of three medications approved by the FDA for the treatment of opioid use disorder. Those physicians who want to treat more than 30 patients at any one time, must take the 8-hour waiver course.

To treat more than 30 patients, Advanced Practice Registered Nurses (APRN) (NP/CNM/CNS/CRNA) and Physician Assistants (PAs) must complete 24 hours of specialized training to prescribe buprenorphine. The training includes 8 hours of waiver training and an additional 16 hours of training.

The first half of the training is a 4.25-hour live webcast. The second half of the course is a 3.75-hour computer-based study. An examination on the computer study must be successfully completed within 30 days of the webinar session.
Instructions on how to log on to Part 2 of the course will be provided via email, ONLY to those who complete the 4.25-hour live webcast in its entirety. Please allow up to 48 hours to receive the email. It is MANDATORY that you are able to view and hear the presentation and participate in the interactive polling questions and case studies in order for the AOAAM to verify your attendance. PHONE ONLY PARTICIPATION DOES NOT QUALIFY FOR PARTICIPATION CREDIT.


CONTINUING MEDICAL EDUCATION: This session has been approved for 4.25 AOA Category 1-A CME credits, providing all requirements have been met. It has also been approved for 4.25 AAFP Prescribed Credit hours, which are eligible for the AMA’s Physician Recognition Award Credit. Participants are required to attend the entire 4.25-hour session, participate in the interactive polling questions and complete the post-test with a passing grade of 70% in order to be eligible for CME credit. CME certificates will become available once all components of the training are fulfilled.

For More Information and FREE training and educational resources visit: www.pcssnow.org.

Funding for this initiative was made possible (in part) by grant no. 1H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

William Morrone, DO, FAOAAM

Medical Director at Recovery Pathways, principal investigator in a naloxone distribution for Mid-Michigan, Medical Director of 35th Circuit Shiawassee County Drug Court

Associate Professor of Family and Community Medicine, Michigan State University for 18 years and was Asst. Program Director of Family Medicine at Synergy Medical Education Alliance and liaison in the Department of Psychiatry. He has presented or published in:

Journal of Addictive Diseases (2015 and 2016), American Journal of Addiction (2013), Substance Abuse (2013), BridgeMI.com 2016-2018 (journalism co-op for setting policy), FoxNews.com (editorial) and CNN.com (news), Weekly medical columns in the Gladwin Record and Courier.

MLive.com, NPR, Arizona Public Radio, American Public Radio and Michigan Public Radio, Adolescent Addiction from the Conrad Hilton Foundation, CORE REMS as a charter master faculty PCSS monthly training sponsored by SAMHSA/CSAT for 9 yr, MOA/MAOFP news letters; AOA publications & advocacy to recognize addiction medicine

Dr. Morrone has published a naloxone book for families.  AMERICAN NARCAN (2017)  www.AmericanNarcan.com

He is triple board certified by the American Board of Addiction Medicine, American College of Osteopathic Family Practitioners and the American Academy of Pain Management. Dr. Morrone was a Ruth Fox faculty for the 42nd ASAM 2011 Medical-Scientific Conference Washington DC and is an active addiction educator and social advocate in pain management.

Nationally and locally he has contributed numerous didactic pieces on opiates, cannabis dependence, primary care, NAS, state based medical marijuana, non-narcotic pain management to providers in recovery; to the state medical and national societies in this area. He is Deputy Medical Director to the Bay County Health Department and principal investigator on Bay County Heroin Task Force.

He also holds a graduate degree in toxicology and pharmacology from the University of Missouri at Kansas City, graduate school of pharmacy. He also completed an MPH in Baltimore, MD.

Most notable to pop culture cable TV news viewers is that he has been on Dr. Drew-HLN, CNN News Room, Nancy Grace-CNN Headline News, Court TV, CNN, Studio “B” FOXNews Channel and MSNBC giving medical opinions on drug addiction or death and the 6 stages of decomposition.  For international overdose awareness day (IOAD) he appeared on 23 TV stations in one day.

Public service is no stranger to Dr. Morrone as he is a Deputy Chief Medical Examiner, a Diplomat of American College of Forensic Examiners and has been a volunteer firefighter. Dr. Morrone is an aggressive advocate for substance abuse treatment and overdose prevention at the FDA, HHS, SAMHSA and congress.  He also trained at the Armed Forces Institute of Pathology (AFIP) in Maryland.

Spent 10 years as Medical Director at Hospice of Michigan, leaving hospice to do addiction full time. Dr. Morrone is a graduate of MSU, served his internship in internal medicine in Lansing at Ingham Regional Medical Center and his residency in family medicine at the Michigan State University statewide campus site at Bay Regional Medical Center. http://wwwAmericanNarcan.com.

This program has been approved for 4.25 AOA Category 1-A CME credits (live webcast session only) providing all requirements have been met. It has also been approved for 4.25 AAFP Prescribed Credit hours, which are eligible for the AMA’s Physician Recognition Award Credit. Participants are required to attend the entire 4.25-hour session, participate in the interactive polling questions and complete the post-test with a passing grade of 70% in order to be eligible for CME credit.

CME certificates will be provided 30 days after the training date.

Key:

Complete
Failed
Available
Locked
Pre-Test
10 Questions  |  1 attempt  |  0/10 points to pass
10 Questions  |  1 attempt  |  0/10 points to pass In order to be CME compliant, a pre-test is required. You will not be graded on this quiz but will be required for CME eligibility. Once completed, regardless of score, you will be allowed to participate in the webinar.
PCSS Office-Based Treatment for Opioid Use Disorders Webinar - 3/28/2022
03/28/2022 at 8:00 PM (EDT)   |  300 minutes
03/28/2022 at 8:00 PM (EDT)   |  300 minutes This is PART 1 of the 8-hour waiver eligibility training. NOTE: This training has a starting time of 5:00 pm Pacific Time Zone. Please check your time zone for start time. Please download the Zoom app prior to training. https://zoom.us/ent?zcid=2582 Physicians are required to apply to the Drug Enforcement Agency for a waiver to prescribe buprenorphine, one of three medications approved by the FDA for the treatment of opioid use disorder. Those physicians who want to treat more than 30 patients at any one time, must take the 8-hour waiver course. To treat more than 30 patients, Advanced Practice Registered Nurses (APRN) (NP/CNM/CNS/CRNA) and Physician Assistants (PAs) must complete 24 hours of specialized training to prescribe buprenorphine. The training includes 8 hours of waiver training and an additional 16 hours of training. The first half of the training is a 4.25-hour live webcast. The second half of the course is a 3.75-hour computer-based study. An examination on the computer study must be successfully completed within 30 days of the webinar session. Instructions on how to log on to Part 2 of the course will be provided via email, ONLY to those who complete the 4.25-hour live webcast in its entirety. Please allow up to 48 hours to receive the email. It is MANDATORY that you are able to view and hear the presentation and participate in the interactive polling questions and case studies in order for the AOAAM to verify your attendance. PHONE ONLY PARTICIPATION DOES NOT QUALIFY FOR PARTICIPATION CREDIT. Access to Part 2 will be emailed to you after successful participation of Part 1 is verified. Please note that this may take up to 48 hours. Funding for this initiative was made possible (in part) by grant no. 1H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
Certificate of Attendance
No credits available  |  Certificate available
No credits available  |  Certificate available This certificate certifies that you have successfully completed Part 1 of the training and have earned 4.25-hours of attendance credit to be applied towards the total required training of 8-hours. You are eligible to advance to Part 2 for the remaining 3.75-hours of training. A follow-up email will be sent to you within 48 hours of the training date with the link and directions on how to access Part 2. If you wish to receive CME credits for the training, please complete the remaining components of Part 1 which include a survey and post-webinar quiz.
OBOT Survey / 4.25-Hour
8 Questions
8 Questions As a CME accredited sponsor, it is required that an evaluation be provided to you in order to be compliant with CME regulations. Once you complete the survey, a certificate will be available for download/print.
Post-Test
10 Questions  |  3 attempts  |  7/10 points to pass
10 Questions  |  3 attempts  |  7/10 points to pass As an accredited sponsor and to meet CME compliance, a post-test is required for CME eligibility. You will need a minimum score of 70% in order to be eligible for CME.
Certificate of Attendance and CME
Up to 4.25 medical credits available  |  Certificate available
Up to 4.25 medical credits available  |  Certificate available The Certificate of Attendance and CME is your combined certificate verifying the training hours from Part 1, along with your CME credits earned. The Certificate of Attendance and CME verifies that the specified hours of training were completed and can be applied toward obtaining the waiver in the office-based treatment of opioid use disorders. Furthermore, please use this certificate to report CME to your respective accrediting board. If you are a D.O., the AOAAM will report your CME credits to the AOA for you. Please allow 90 days for the AOAAM to complete this process.